Preparation and Evaluation of Long-Acting Injectable Levocetirizine Prodrug Formulation
<b>Background/Objectives</b>: Levocetirizine (LCZ) is a second-generation antihistamine with minimal central nervous system effects. However, its short half-life necessitates daily dosing, potentially reducing adherence in pediatric populations. This study aimed to develop a long-acting injectable L...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2025-06-01
|
| Serija: | Pharmaceutics |
| Teme: | |
| Online pristup: | https://www.mdpi.com/1999-4923/17/7/806 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|